These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6234088)

  • 1. [Treatment and prevention of ABO incompatibility during pregnancy with combined traditional Chinese medicine and western medicine and its effect on fetus and newborn].
    Li ET
    Zhong Xi Yi Jie He Za Zhi; 1984 Mar; 4(3):137-8. PubMed ID: 6234088
    [No Abstract]   [Full Text] [Related]  

  • 2. [MATERNAL-FETAL INCOMPATIBILITY IN THE ABO AND RH HR SYSTEMS].
    MONGEAMADOR R; LORIACORTES R; VARGASSANDINO C; CHAVESVILLALOBOS E
    Rev Med Costa Rica; 1964 Aug; 21():317-26. PubMed ID: 14211181
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 4. [Laboratory study of traditional Chinese medicine for the prevention and treatment of hemolytic diseases of the newborn infant].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):207-9, 256. PubMed ID: 6543580
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effective prophylaxis in ABO heterospecific pregnancy by complex drug therapy and restoration of the hemodynamic balance].
    Kese G
    Zentralbl Gynakol; 1966 Jul; 88(30):1011-5. PubMed ID: 6011522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
    Cwik J
    Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isoimmunization in the ABO system caused by obstetrician or pregnancy complications (control groups)].
    Sauer J; Kulich V
    Zentralbl Gynakol; 1965 Dec; 87(52):1780-8. PubMed ID: 5885709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological enhancement in pregnancy: necessity of materno-fetal incompatibility for a good result of fetoplacental homograft].
    Cardone A; Tolino A; Dimita U; Frollo G; Zarcone R; Scarcella A; Iervolino P; De Placido G
    Riv Ital Ginecol; 1977; 58(6):451-60. PubMed ID: 122036
    [No Abstract]   [Full Text] [Related]  

  • 10. [COMPARATIVE STUDIES ON THE SEROLOGICAL DIAGNOSIS OF ABO ERYTHROBLASTOSIS].
    MATTHES M; SIEGRIST D
    Bibl Haematol; 1964; 20():260-5. PubMed ID: 14237835
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Rh immunization in Finland. A national study, 1969--1977.
    Eklund J
    Acta Paediatr Scand Suppl; 1978; (274):1-57. PubMed ID: 82366
    [No Abstract]   [Full Text] [Related]  

  • 12. Practical effects of blood group incompatibility between mother and fetus.
    Clarke CA
    Br Med J; 1972 Apr; 2(5805):90-5. PubMed ID: 5062951
    [No Abstract]   [Full Text] [Related]  

  • 13. Irregular antibodies in pregnant women.
    Smith BD; Haber JM; Queenan JT
    Obstet Gynecol; 1967 Jan; 29(1):118-24. PubMed ID: 4959779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemolytic disease of the newborn in first-born infants. (Clinical contribution)].
    Baratta A; Torsiglieri W
    Quad Clin Ostet Ginecol; 1966 Sep; 21(9):587-94. PubMed ID: 5993026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neonatal jaundice with ABO incompatibility. Frequency, treatment and immediate results. Evaluation of over 10,000 newborn infants].
    Crosato M; Benso L; Bogetti G
    Minerva Pediatr; 1970 Jul; 22(28):1409-11. PubMed ID: 5515764
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of epsilon-aminocaproic acid on the antigen-antibody reaction.
    Musiatowicz J; Jezuita J; Bielecki M
    Br J Exp Pathol; 1965 Jun; 46(3):274-7. PubMed ID: 4953388
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P; Hinselmann M; Frey P
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood group incompatible pregnancy].
    Okubo M; Maeda H; Suzuki M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():727-30. PubMed ID: 16111382
    [No Abstract]   [Full Text] [Related]  

  • 19. [Massive feto-maternal and materno-fetal hemorrhage].
    Valbonesi M; Cinollo G; Rivabella L; Serra G
    Minerva Pediatr; 1978 Jul; 30(14):1149-52. PubMed ID: 97508
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
    Zlatnik FJ
    Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.